HBV entry and its application to the drug development
Watashi, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 372-376
2015
ISSN/ISBN: 0047-1852 PMID: 26845961 Document Number: 683980
Document emailed within 1 workday
Related Documents
Kadow, J.; Wang, H-Gene.Heidi.; Lin, P-Fang. 2006: Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development Current Opinion in Investigational Drugs 7(8): 721-726Inoue, R.; Ito, Y.; Mori, Y. 2002: The TRP proteins, a rapidly expanding Ca2+ entry channel family and a new molecular target for drug development Nihon Rinsho. Japanese Journal of Clinical Medicine 60(1): 18-24
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Kobata, A. 2003: Possible application of milk oligosaccharides for drug development Chang Gung Medical Journal 26(9): 621-636
Knapp, D.A.; Knapp, D.E.; Brandon, B.M.; West, S. 1974: Development and application of criteria in drug use review programs American Journal of Hospital Pharmacy 31(7): 648-656
Yamada, H. 2013: Application of translational research to drug discovery and development Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(3): 121
Peelen, L.; Peek, N.; de Keizer, N.; de Jonge, E. 2005: Investigating the effect of differences in entry criteria on trial populations: a method with an application in severe sepsis Studies in Health Technology and Informatics 116: 1004-1009
Rhea, S. 2010: Former drug execs lose appeal. Bid for re-entry to Medicare is denied Modern Healthcare 40(51): 14
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
O'Donohue, W.J. 1982: Development of an entry level examination for respiratory care practitioners Respiratory Care 27(9): 1058-1062
Okbi, A.E.; Allouache, A.; Facihi, M. 1975: Dissection of recurrent nerves during thyroidectomies. Description of a personal method of dissecting the nerve from its entry in the neck to its entry in the larynx Chirurgie; Memoires de l'Academie de Chirurgie 101(11): 811-823
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Romansky, M.A. 1983: View from the Nation's Capital. Investigational new drug (IND) and new drug application (NDA) Journal of Clinical Psychopharmacology 3(3): 193-194
Motati, D.Reddy.; Uredi, D.; Watkins, E.Blake. 2019: The Discovery and Development of Oxalamide and Pyrrole Small Molecule Inhibitors of gp120 and HIV Entry - A Review Current Topics in Medicinal Chemistry 19(18): 1650-1675
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62
Prochaczek, F.; Gałecka, J.; Becker, A. 1988: Use of non-invasive transdermal stimulation of the heart in selecting an anti-arrhythmia drug in a patient with supraventricular paroxysmal tachycardia with a re-entry mechanism within the atrioventricular node Kardiologia Polska 31(6): 337-342
Kim, T. 2021: Age culture, school-entry cutoff, and the choices of birth month and school-entry timing in South Korea Journal of Demographic Economics 87(1): 33-65
Bobath, B. 1971: Motor development, its effect on general development, and application to the treatment of cerebral palsy PhysioTherapy 57(11): 526-532
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904